Summary

Managing hyperglycemia under the sepsis code

Pablo Matías Soler1, Marina Gil Mosquera1, Paula Mostaza Gallar2, Raúl Perales Muñoz1, Juan María González del Castillo1, Manuel Fuentes Ferrer3

Affiliation of the authors

1Servicio de Urgencias. Hospital Clínico San Carlos. Madrid, Spain. 2Servicio de Urgencias. Hospital de Getafe. Madrid, Spain. 3Servicio de Medicina Preventiva. Hospital Clínico San Carlos. Madrid, Spain.

DOI

Quote

Matías Soler P, Gil Mosquera M, Mostaza Gallar P, Perales Muñoz R, González del Castillo JM, Fuentes Ferrer M. Managing hyperglycemia under the sepsis code. Rev Esp Urg Emerg. 2022;1:93–6

Summary

BACKGROUND. The sepsis code is a tool for the early detection and treatment of patients with sepsis. Hyperglycemia is a known risk factor for poor in-hospital prognosis in the management of sepsis. We do not currently know if hyperglycemia is being treated in patients assessed under the code and if treatment has an impact on prognosis.
MATERIALS AND METHODS. Retrospective observational study of all patients over the age of 18 years treated under the sepsis code in an emergency department from May to September 2018.
RESULTS. Data for 128 patients were included. Most infections involved the respiratory tract (55%). Hyperglycemia was present in 37.5%, and 19% of them received treatment for it. Although mortality tended to be lower in patients whose hyperglycemia was treated, the difference was not statistically significant.
CONCLUSIONS. Hyperglycemia is not being treated in sepsis-code cases. Further studies are needed to understand the prognostic implications.

 

More articles by the authors

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.